Hyperphagia and increased meal size are responsible for weight gain in rats treated sub-chronically with olanzapine

Psychopharmacology

Volumn 203, Issue 4, 2009, Pages 693-702

  Davoodi, Nima ^a   Kalinichev, Mikhail ^b   Korneev, Sergei A ^a   Clifton, Peter G ^a  

^a UNIVERSITY OF SUSSEX   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Antipsychotic; Appetite; Hyperphagia; Hypothalamus; Meal size; mRNA; Olanzapine; Pair feeding; Rat; Weight gain

Indexed keywords

MELANIN CONCENTRATING HORMONE; MESSENGER RNA; NEUROPEPTIDE Y; OLANZAPINE; OREXIN; PROOPIOMELANOCORTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; HYPERPHAGIA; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; EATING; FEMALE; HYPERPHAGIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; NEUROPEPTIDE Y; NEUROPEPTIDES; PRO-OPIOMELANOCORTIN; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; WEIGHT GAIN;

EID: 63449100443     PISSN: 00333158     EISSN: 14322072     Source Type: Journal    
DOI: 10.1007/s00213-008-1415-1     Document Type: Article

References (54)

1. A Ahnaou AA Megens WH Drinkenburg 2003 The atypical antipsychotics risperidone, clozapine and olanzapine differ regarding their sedative potency in rats Neuropsychobiology 48 47 54
2. VL Albaugh CR Henry NT Bello A Hajnal SL Lynch B Halle CJ Lynch 2006 Hormonal and metabolic effects of olanzapine and clozapine related to body weight in rodents Obesity (Silver Spring) 14 36 51
3. DB Allison JL Mentore M Heo LP Chandler JC Cappelleri MC Infante PJ Weiden 1999 Antipsychotic-induced weight gain: a comprehensive research synthesis Am J Psychiatry 156 1686 1696
4. AA Arjona SX Zhang B Adamson RJ Wurtman 2004 An animal model of antipsychotic-induced weight gain Behav Brain Res 152 121 127
5. T Baptista Q Contreras L Teneud MA Albornoz A Acosta X Paez M de Quijada A LaCruz L Hernandez 1998 Mechanism of the neuroleptic-induced obesity in female rats Prog Neuropsychopharmacol Biol Psychiatry 22 187 198
6. BR Basson BJ Kinon CC Taylor KA Szymanski JA Gilmore GD Tollefson 2001 Factors influencing acute weight change in patients with schizophrenia treated with olanzapine, haloperidol, or risperidone J Clin Psychiatry 62 231 238
7. D Briffa T Meehan 1998 Weight changes during clozapine treatment Aust N Z J Psychiatry 32 718 721
8. FP Bymaster DL Nelson NW DeLapp JF Falcone K Eckols LL Truex MM Foreman VL Lucaites DO Calligaro 1999 Antagonism by olanzapine of dopamine D1, serotonin2, muscarinic, histamine H1 and alpha 1-adrenergic receptors in vitro Schizophr Res 37 107 122
9. S Choi B DiSilvio J Unangst JD Fernstrom 2007 Effect of chronic infusion of olanzapine and clozapine on food intake and body weight gain in male and female rats Life Sci 81 1024 1030
10. PG Clifton 2000 Meal patterning in rodents: psychopharmacological and neuroanatomical studies Neurosci Biobehav Rev 24 213 222
11. PG Clifton IN Rusk SJ Cooper 1991 Effects of dopamine D1 and dopamine D2 antagonists on the free feeding and drinking patterns of rats Behav Neurosci 105 272 281
12. PG Clifton MD Lee CT Dourish 2000 Similarities in the action of Ro 60-0175, a 5-HT2Creceptor agonist, and d-fenfluramine on feeding patterns in the rat Psychopharmacology 152 256 267
13. GD Cooper LC Pickavance JP Wilding JC Halford AJ Goudie 2005 A parametric analysis of olanzapine-induced weight gain in female rats Psychopharmacology (Berl) 181 80 89
14. GD Cooper LC Pickavance JP Wilding JA Harrold JC Halford AJ Goudie 2007 Effects of olanzapine in male rats: enhanced adiposity in the absence of hyperphagia, weight gain or metabolic abnormalities J Psychopharmacol 21 405 413
15. N Davoodi M Kalinichev PG Clifton 2008 Comparative effects of olanzapine and ziprasidone on hypophagia induced by enhanced histamine neurotransmission in the rat Behav Pharmacol 19 121 128
16. CM Edwards S Abusnana D Sunter KG Murphy MA Ghatei SR Bloom 1999 The effect of the orexins on food intake: comparison with neuropeptide Y, melanin-concentrating hormone and galanin J Endocrinol 160 R7 R12
17. J Fadel M Bubser AY Deutch 2002 Differential activation of orexin neurons by antipsychotic drugs associated with weight gain J Neurosci 22 6742 6746
18. MJ Fell KM Marshall J Williams JC Neill 2004 Effects of the atypical antipsychotic olanzapine on reproductive function and weight gain in female rats J Psychopharmacol 18 149 155
19. MJ Fell JC Neill C Rao KM Marshall 2005 Effects of sub-chronic antipsychotic drug treatment on body weight and reproductive function in juvenile female rats Psychopharmacology (Berl) 182 499 507
20. MJ Fell N Anjum K Dickinson KM Marshall LM Peltola S Vickers S Cheetham JC Neill 2007 The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats Psychopharmacology (Berl) 194 221 231
21. D Gothelf B Falk P Singer M Kairi M Phillip L Zigel I Poraz S Frishman N Constantini G Zalsman A Weizman A Apter 2002 Weight gain associated with increased food intake and low habitual activity levels in male adolescent schizophrenic inpatients treated with olanzapine Am J Psychiatry 159 1055 1057
22. AJ Goudie JA Smith JC Halford 2002 Characterization of olanzapine-induced weight gain in rats J Psychopharmacol 16 291 296
23. Hartfield AW (2003) Effects of atypical antipsychotics on feeding and drinking in rats: towards a model of obesity associated with antipsychotic drug treatment. PhD thesis, Experimental Psychology, University of Sussex, pp 1-382
24. AW Hartfield NA Moore PG Clifton 2003 Effects of clozapine, olanzapine and haloperidol on the microstructure of ingestive behaviour in the rat Psychopharmacology (Berl) 167 115 122
25. AW Hartfield NA Moore PG Clifton 2006 Effects of atypical antipsychotic drugs on intralipid intake and cocaine-induced hyperactivity in rats Neuropsychopharmacology 31 1938 1945
26. XF Huang C Deng K Zavitsanou 2006 Neuropeptide Y mRNA expression levels following chronic olanzapine, clozapine and haloperidol administration in rats Neuropeptides 40 213 219
27. M Kalinichev C Rourke AJ Daniels MK Grizzle CS Britt DM Ignar DN Jones 2005 Characterisation of olanzapine-induced weight gain and effect of aripiprazole vs olanzapine on body weight and prolactin secretion in female rats Psychopharmacology (Berl) 182 220 231
28. M Kalinichev C Rourke DN Jones 2006 Body weights and plasma prolactin levels in female rats treated subchronically with ziprasidone versus olanzapine Behav Pharmacol 17 289 292
29. GA Kennett MD Wood F Bright B Trail G Riley V Holland KY Avenell T Stean N Upton S Bromidge IT Forbes AM Brown DN Middlemiss TP Blackburn 1997 SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist Neuropharmacology 36 609 620
30. SL Kirk M Cahir GP Reynolds 2006 Clozapine, but not haloperidol, increases neuropeptide Y neuronal expression in the rat hypothalamus J Psychopharmacol 20 577 579
31. M Kluge A Schuld H Himmerich M Dalal A Schacht PM Wehmeier D Hinze-Selch T Kraus RW Dittmann T Pollmacher 2007 Clozapine and olanzapine are associated with food craving and binge eating: results from a randomized double-blind study J Clin Psychopharmacol 27 662 666
32. M Lambert R Holzbach S Moritz N Postel M Krausz D Naber 2003 Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders Int Clin Psychopharmacol 18 251 260
33. MD Lee PG Clifton 1992 Partial reversal of fluoxetine anorexia by the 5-HT antagonist metergoline Psychopharmacology (Berl) 107 359 364
34. MD Lee PG Clifton 2002 Meal patterns of free feeding rats treated with clozapine, olanzapine, or haloperidol Pharmacol Biochem Behav 71 147 154
35. AS Levine JE Morley 1984 Neuropeptide Y: a potent inducer of consummatory behavior in rats Peptides 5 1025 1029
36. S Li G Pelletier 1986 The role of dopamine in the control of neuropeptide Y neurons in the rat arcuate nucleus Neurosci Lett 69 74 77
37. DS Ludwig KG Mountjoy JB Tatro JA Gillette RC Frederich JS Flier E Maratos-Flier 1998 Melanin-concentrating hormone: a functional melanocortin antagonist in the hypothalamus Am J Physiol 274 E627 E633
38. J Minet-Ringuet PC Even M Lacroix D Tome R de Beaurepaire 2006 A model for antipsychotic-induced obesity in the male rat Psychopharmacology (Berl) 187 447 454
39. J Minet-Ringuet PC Even P Valet C Carpene V Visentin D Prevot D Daviaud A Quignard-Boulange D Tome R de Beaurepaire 2007 Alterations of lipid metabolism and gene expression in rat adipocytes during chronic olanzapine treatment Mol Psychiatry 12 562 571
40. E Obuchowicz 1996 Long-term treatment with chlorpromazine and haloperidol but not with sulpiride and clozapine markedly elevates neuropeptide Y-like immunoreactivity in the rat hypothalamus Neuropeptides 30 471 478
41. A Ortega-Alvaro J Gibert-Rahola JA Mico 2006 Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats Prog Neuropsychopharmacol Biol Psychiatry 30 104 111
42. MW Pfaffl 2001 A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 e45
43. B Pouzet T Mow M Kreilgaard S Velschow 2003 Chronic treatment with antipsychotics in rats as a model for antipsychotic-induced weight gain in human Pharmacol Biochem Behav 75 133 140
44. RM Procyshyn A Chau G Tse 2004 Clozapine's effects on body weight and resting metabolic rate: a case series Schizophr Res 66 159 162
45. D Qu DS Ludwig S Gammeltoft M Piper MA Pelleymounter MJ Cullen WF Mathes R Przypek R Kanarek E Maratos-Flier 1996 A role for melanin-concentrating hormone in the central regulation of feeding behaviour Nature 380 243 247
46. JD Salamone MS Cousins C Maio M Champion T Turski J Kovach 1996 Different behavioral effects of haloperidol, clozapine and thioridazine in a concurrent lever pressing and feeding procedure Psychopharmacology (Berl) 125 105 112
47. C Seale R Chaplin P Lelliott A Quirk 2007 Antipsychotic medication, sedation and mental clouding: an observational study of psychiatric consultations Soc Sci Med 65 698 711
48. JK Sharpe TJ Stedman NM Byrne C Wishart AP Hills 2006 Energy expenditure and physical activity in clozapine use: implications for weight management Aust N Z J Psychiatry 40 810 814
49. Z Thornton-Jones JC Neill GP Reynolds 2002 The atypical antipsychotic olanzapine enhances ingestive behaviour in the rat: a preliminary study J Psychopharmacol 16 35 37
50. SA Varvel RE Vann LE Wise SD Philibin JH Porter 2002 Effects of antipsychotic drugs on operant responding after acute and repeated administration Psychopharmacology (Berl) 160 182 191
51. HS Vestri L Maianu DR Moellering WT Garvey 2007 Atypical antipsychotic drugs directly impair insulin action in adipocytes: effects on glucose transport, lipogenesis, and antilipolysis Neuropsychopharmacology 32 765 772
52. M Virkkunen K Wahlbeck A Rissanen H Naukkarinen A Franssila-Kallunki 2002 Decrease of energy expenditure causes weight increase in olanzapine treatment-a case study Pharmacopsychiatry 35 124 126
53. NM Wallingford P Sinnayah FP Bymaster KM Gadde RK Krishnan AA McKinney RP Landbloom GD Tollefson MA Cowley 2008 Zonisamide prevents olanzapine-associated hyperphagia, weight gain, and elevated blood glucose in rats Neuropsychopharmacology 33 2922 2933
54. PJ Weiden JA Mackell DD McDonnell 2004 Obesity as a risk factor for antipsychotic noncompliance Schizophr Res 66 51 57